DF/Net and TCD launch COVID-19 Treatment Trial in South Africa

DF/Net and TCD launch COVID-19 Treatment Trial in South Africa
June 10, 2020 Laura Beauregard

2020/06/11: The last week of May saw a milestone for the newest study that DF/Net is involved in -- the Kickoff Meeting to launch a COVID-19 Treatment Trial in South Africa, sponsored by Medicines for Malaria Venture (MMV) and Shin Poong Pharm. Co (SPP).

DF/Net is partnering with TCD to provide the clinical trial services for this important study, which will be recruiting participants in Johannesburg, South Africa.  The study timeline is tight, challenging us to be setup in record time.  As result of social distancing and other Covid-related restrictions, this trial will be conducted using e-technologies for data collection and a remote monitoring approach to limit exposure.

Thanks to the DF/Net team for all your efforts, breaking records to make this study possible during the global pandemic. Thanks also to MMV, TCD and other study collaborators, for trusting us as a partner in this important clinical trial.